US bill proposes US$20M for 4DMedical
- US lawmakers introduced the AIRCARE for Vets Act to fund a US$20 million lung imaging pilot programme.
- Following the announcement, the 4DMedical share price was down at $3.74.
- The legislation aims to deploy four-dimensional technology across the Department of Veterans Affairs to detect service-related respiratory disease.
US lawmakers introduced a bipartisan bill authorising US$20 million for a veterans lung imaging pilot featuring 4DMedical (ASX:4DX) software.
The AIRCARE for Vets Act builds on US congressional actions since 2022 that urged military healthcare providers to adopt advanced respiratory surveillance.
Introduced by Representatives Juan Ciscomani and Chris Pappas, the legislation directs the agency to establish testing for respiratory disorders among exposed service members.
Peer-reviewed multicentre research demonstrated that the company's software identified deployment-related lung conditions even when conventional CT scans and spirometry showed normal results.
Following the announcement, the 4DMedical share price was down at $3.74.
The company focuses on commercialising its proprietary algorithm that converts standard hospital X-ray equipment into four-dimensional lung function scans.
The legislative push follows earlier regulatory milestones in the United States, where the medical device maker has expanded its clinical trials and commercial network.
